The challenge of paediatric efavirenz dosing: implications and way forward for the sub-Saharan Africa

AIDS. 2014 Aug 24;28(13):1855-7. doi: 10.1097/QAD.0000000000000372.
No abstract available

MeSH terms

  • Adolescent
  • Africa South of the Sahara
  • Age Factors
  • Alkynes
  • Anti-HIV Agents / administration & dosage*
  • Anti-HIV Agents / adverse effects*
  • Benzoxazines / administration & dosage*
  • Benzoxazines / adverse effects*
  • Child
  • Child, Preschool
  • Cyclopropanes
  • Female
  • HIV Infections / drug therapy*
  • Humans
  • Infant
  • Male

Substances

  • Alkynes
  • Anti-HIV Agents
  • Benzoxazines
  • Cyclopropanes
  • efavirenz